Insider Transactions in Q2 2021 at Organicell Regenerative Medicine, Inc. (OCEL)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 11
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
50,100
-0.03%
|
$0
$0.31 P/Share
|
|
May 11
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
75,000
-0.02%
|
$0
$0.32 P/Share
|
|
May 11
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.35 P/Share
|
|
May 11
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
75,000
-0.02%
|
$0
$0.32 P/Share
|
|
May 10
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.06%
|
$0
$0.27 P/Share
|
|
May 10
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.04%
|
$0
$0.27 P/Share
|
|
May 10
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.27 P/Share
|
|
May 10
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.26 P/Share
|
|
May 07
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
89,900
-0.04%
|
$0
$0.25 P/Share
|
|
May 07
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
90,000
-0.03%
|
$0
$0.26 P/Share
|
|
May 07
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
80,000
-0.03%
|
$0
$0.27 P/Share
|
|
May 07
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
90,000
-0.02%
|
$0
$0.26 P/Share
|
|
May 06
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
40,000
-0.05%
|
$0
$0.26 P/Share
|
|
May 06
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
40,000
-0.03%
|
$0
$0.26 P/Share
|
|
May 06
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
40,000
-0.03%
|
$0
$0.26 P/Share
|
|
May 06
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
40,000
-0.02%
|
$0
$0.26 P/Share
|
|
May 05
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
75,000
-0.05%
|
$0
$0.29 P/Share
|
|
May 05
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
75,000
-0.03%
|
$0
$0.29 P/Share
|
|
May 05
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
75,000
-0.03%
|
$0
$0.3 P/Share
|
|
May 05
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
75,000
-0.02%
|
$0
$0.29 P/Share
|
|
May 04
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.4 P/Share
|
|
May 04
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.04%
|
$0
$0.4 P/Share
|
|
May 04
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.06%
|
$0
$0.4 P/Share
|
|
May 04
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.42 P/Share
|
|
May 03
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.25 P/Share
|
|
Apr 30
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.04%
|
$0
$0.47 P/Share
|
|
Apr 30
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.06%
|
$0
$0.5 P/Share
|
|
Apr 30
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.5 P/Share
|
|
Apr 30
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.45 P/Share
|
|
Apr 29
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.48 P/Share
|
|
Apr 29
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.45 P/Share
|
|
Apr 06
2021
|
Albert Mitrani Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+2.87%
|
-
|
|
Apr 06
2021
|
Maria Ines Mitrani Chief Science Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+4.04%
|
-
|
|
Apr 06
2021
|
Ian T Bothwell Interim CEO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+3.22%
|
-
|
|
Apr 06
2021
|
George Craig Shapiro Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,500,000
+1.79%
|
-
|